Description
The options (ASX: RADO) of Radiopharm Theranostics Limited (‘RAD’) will be suspended immediately in accordance with Listing Rule 17.3, as there will be no deferred settlement trading. The options are expected to be quoted on a normal settlement basis on Monday, 28 November 2022.
The suspension only applies to RAD’s options (ASX: RADO) and does not apply to any other quoted securities of RAD.
Issued by
Angel He
Adviser, Listings Compliance (Sydney)
Download this document
